Thiazide effects and adverse effects: Insights from molecular genetics

Hypertension

Volumn 54, Issue 2, 2009, Pages 196-202

  Ellison, David H ^a,b   Loffing, Johannes ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; HYDROCHLOROTHIAZIDE; HYDROFLUMETHIAZIDE; INDAPAMIDE; POTASSIUM; SODIUM CHLORIDE COTRANSPORTER; THIAZIDE DIURETIC AGENT;

CHOLESTEROL BLOOD LEVEL; DRUG COST; DRUG EFFICACY; ELECTROCARDIOGRAPHY; GENE MUTATION; GLOMERULUS FILTRATION RATE; GLUCOSE INTOLERANCE; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; IMPAIRED GLUCOSE TOLERANCE; KIDNEY INJURY; MOLECULAR GENETICS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SLC12A3 GENE; URIC ACID BLOOD LEVEL; VASODILATATION; ANIMAL; BLOOD PRESSURE MEASUREMENT; CHEMICALLY INDUCED DISORDER; FEMALE; GENETICS; HOSPITALIZATION; KIDNEY DISEASE; MALE; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; RAT; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ANIMALS; BLOOD PRESSURE DETERMINATION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; KIDNEY DISEASES; MALE; MOLECULAR BIOLOGY; PROGNOSIS; RATS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; THIAZIDES; TREATMENT OUTCOME;

EID: 68549118943     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.129171     Document Type: Review

References (88)

1. Appel LJ. The verdict from ALLHAT-thiazide diuretics are the preferred initial therapy for hypertension. JAMA. 2002 Dec 18;288:3039-3042.
2. Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, Johnston CI, McNeil JJ, Macdonald GJ, Marley JE, Morgan TO, West MJ. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med. 2003;348:583-592.
3. Reungjui S, Hu H, Mu W, Roncal CA, Croker BP, Patel JM, Nakagawa T, Srinivas T, Byer K, Simoni J, Wesson D, Sitprija V, Johnson RJ. Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. Kidney Int. 2007;72:1483-1492.
4. Reungjui S, Roncal CA, Mu W, Srinivas TR, Sirivongs D, Johnson RJ, Nakagawa T. Thiazide diuretics exacerbate fructose-induced metabolic syndrome. J Am Soc Nephrol. 2007;18:2724-2731.
5. Rovin BH, Hebert LA. Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker. Kidney Int. 2007;72:1423-1426.
6. Hebert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993;153:578-581.
7. Moser M. Diuretics should continue to be one of the preferred initial therapies in the management of hypertension: the argument for. J Clin Hypertens (Greenwich). 2005;7:111-116, quiz 121-112.
8. Houston MC. Thiazides and thiazide-like diuretics in hypertension. Ann Intern Med. 1985;103:303.
9. Hawkins RG, Houston MC. Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis. Am J Hypertens. 2005;18:744-749.
10. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.
11. Hughes AD. How do thiazide and thiazide-like diuretics lower blood pressure. J Renin Angiotensin Aldosterone Syst. 2004;5:155-160.
12. Pecker MS. Pathophysiologic effects and strategies for long-term diuretic treatment of hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press; 1990:2143-2168.
13. Kaplan NM. Treatment of hypertension: drug therapy. In: Kaplan's Clinical Hypertension. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:237-338.
14. Papademetriou V, Sica DA, Izzo JL Jr. Thiazide and loop diuretics. In: Izzo JL Jr, Black HR, eds. Hypertension Primer. Philadelphia, PA: Lippincott Williams & Wilkins; 2003:411-414.
15. Sica DA. Thiazide and loop diuretics. In: Izzo JL Jr, Sica DA, Black HR, eds. Hypertension Primer. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:439-442.
16. Bennett WM, McDonald WJ, Kuehnel E, Hartnett MN, Porter GA. Do diuretics have antihypertensive properties independent of natriuresis? Clin Pharmacol Ther. 1977;22:499-504.
17. Pickkers P, Hughes AD. Relaxation and decrease in [Ca2+]i by hydrochlorothiazide in guinea-pig isolated mesenteric arteries. Br J Pharmacol. 1995;114:703-707.
18. Pickkers P, Hughes AD, Russel FG, Thien T, Smits P. Thiazide-induced vasodilation in humans is mediated by potassium channel activation. Hypertension. 1998;32:1071-1076.
19. Pickkers P, Garcha RS, Schachter M, Smits P, Hughes AD. Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide. Hypertension. 1999;33:1043-1048.
20. Velázquez H, Wright FS. Effects of diuretic drugs on Na, Cl, and K transport by rat renal distal tubule. Am J Physiol. 1986;250:F1013- F1023.
21. Ellison DH, Velázquez H, Wright FS. Thiazide sensitive sodium chloride cotransport in the early distal tubule. Am J Physiol. 1987;253: F546-F554.
22. Obermüller N, Bernstein PL, Velázquez H, Reilly R, Moser D, Ellison DH, Bachmann S. Expression of the thiazide-sensitive Na-Cl cotransporter in rat and human kidney. Am J Physiol. 1995;269:F900-F910.
23. Bachmann S, Velázquez H, Obermüller N, Reilly RF, Moser D, Ellison DH. Expression of the thiazide-sensitive Na-Cl cotransporter by rabbit distal convoluted tubule cells. J Clin Invest. 1995;96:2510-2514.
24. Dvorak MM, De Joussineau C, Carter DH, Pisitkun T, Knepper MA, Gamba G, Kemp PJ, Riccardi D. Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone. J Am Soc Nephrol. 2007;18:2509-2516.
25. Bazzini C, Vezzoli V, Sironi C, Dossena S, Ravasio A, De Biasi S, Garavaglia M, Rodighiero S, Meyer G, Fascio U, Furst J, Ritter M, Botta G, Paulmichl M. Thiazide-sensitive NaCl-cotransporter in the intestine: possible role of hydrochlorothiazide in the intestinal Ca2+ uptake. J Biol Chem. 2005;280:19902-19910.
26. Gamba G, Miyanoshita A, Lombardi M, Lytton J, Lee WS, Hediger MA, Hebert SC. Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)chloride cotransporter family expressed in kidney. J Biol Chem. 1994;269:17713-17722.
27. Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitelman HJ, Lifton RP. Gitelman's variant of Bartter's syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;12:24-30.
28. Kunchaparty S, Palcso M, Berkman J, Velázquez H, Bernstein P, Reilly RF, Ellison DH. Defective processing and expression of the thiazidesensitive Na-Cl cotransporter as a cause Gitelman's Syndrome. Am J Physiol Renal Physiol. 1999;277:F643-F649.
29. Sartori M, Parotto E, Bonso E, Semplicini A, Palatini P, Pessina AC, Calo LA. Autonomic nervous system function in chronic hypotension associated with Bartter and Gitelman syndromes. Am J Kidney Dis. 2007;49: 330-335.
30. Cruz DN, Simon DB, Nelson-Williams C, Farhi A, Finberg K, Burleson L, Gill JR, Lifton RP. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension. 2001;37:1458-1464.
31. Calo L, Davis PA, Semplicini A. Control of vascular tone in the syndromes of Bartter and Gitelman. Crit Rev Clin Lab Sci. 2000;37:503-522.
32. Calo L, D'Angelo A, Cantaro S, Bordin MC, Favaro S, Antonello A, Borsatti A. Increased urinary NO2-/NO3-and cyclic guanosine monophosphate levels in patients with Bartter's syndrome: relationship to vascular reactivity. Am J Kidney Dis. 1996;27:784-789.
33. Calo L, Ceolotto G, Milani M, Pagnin E, van den Heuvel LP, Sartori M, Davis PA, Costa R, Semplicini A. Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. Kidney Int. 2001;60: 882-889.
34. Calo L, Davis PA, Semplicini A. Reduced content of alpha subunit of Gq protein content in monocytes of Bartter and Gitelman syndromes: relationship with vascular hyporeactivity. Kidney Int. 2002;61:353-354.
35. Geleijnse JM, Kok FJ, Grobbee DE. Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens. 2003;17:471-480.
36. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z. Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab. 2002;87:3248-3254.
37. Yang SS, Morimoto T, Rai T, Chiga M, Sohara E, Ohno M, Uchida K, Lin SH, Moriguchi T, Shibuya H, Kondo Y, Sasaki S, Uchida S. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. Cell Metab. 2007;5:331-344.
38. Lalioti MD, Zhang J, Volkman HM, Kahle KT, Hoffmann KE, Toka HR, Nelson-Williams C, Ellison DH, Flavell R, Booth CJ, Lu Y, Geller DS, Lifton RP. Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet. 2006;38:1124-1132.
39. Paver WK, Pauline GJ. Hypertension and hyperpotassemia without renal disease in a young male. Med J Aust. 1964;2:305-306.
40. Tobian L Jr. Why do thiazide diuretics lowere blood pressure in essential hypertension? Annu Rev Pharmacol. 1967;7:399-408.
41. Shah S, Khatri I, Freis ED. Mechanism of antihypertensive effect of thiazide diuretics. Am Heart J. 1978;95:611-618.
42. Manning RD Jr, Coleman TG, Samar RE. Autoregulation, cardiac output, total peripheral resistance and the 'quantitative cascade' of the kidney-blood volume system for pressure control. In: Guyton AC, ed. Arterial Pressure and Hypertension. Philadelphia, PA: WB Saunders; 1980:139-155.
43. Hall JE, Jackson TE. The basic kidney-blood volume-pressure regulatory system: the pressure diuresis and natriuresis phenomena. In: Guyton AC, ed. Arterial Pressure and Hypertension. Philadelphia, PA: WB Saunders Company; 1998:87-99.
44. Hollander W, Chobanian AV, Wilkins RW. Relationship between diuretic and antihypertensive effects of chlorothiazide and mercurial diuretics. Circulation. 1959;19:827-838.
45. Freis ED, Wanko A, Wilson IM, Parrish AE. Chlorothiazide in hypertensive and normotensive patients. Ann N Y Acad Sci. 1958;71:450-455.
46. Sullivan JM, Dluhy RG, Wacker WE, Solomon HS, Williams GH, Samaha JK. Interrelationships among thiazide diuretics and calcium, magnesium, sodium, and potassium balance in normal and hypertensive man. J Clin Pharmacol. 1978;18:530-543.
47. Bolland MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reid IR. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int. 2007;18: 479-486.
48. Colussi G, Bettinelli A, Tedeschi S, De Ferrari ME, Syren ML, Borsa N, Mattiello C, Casari G, Bianchetti MG. A thiazide test for the diagnosis of renal tubular hypokalemic disorders. Clin J Am Soc Nephrol. 2007;2: 454-460.
49. Goldfarb DS, Chan AJ, Hernandez D, Charney AN. Effect of thiazides on colonic NaCl absorption: role of carbonic anhydrase. Am J Physiol Renal Fluid Electrolyte Physiol. 1991;261:F452-F458.
50. Terada Y, Knepper MA. Thiazide-sensitive NaCl absorption in rat cortical collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol. 1990;259:F519-F528.
51. Rouch AJ, Chen L, Troutman SL, Schafer JA. Na+ transport in isolated rat CCD: effects of bradykinin, ANP, clonidine, and hydrochlorothiazide. Am J Physiol Renal Fluid Electrolyte Physiol. 1991;260:F86-F95.
52. Kaplan NM. Our appropriate concern about hypokalemia. Am J Med. 1984;77:1-4.
53. Harrington JT, Isner JM, Kassirer JP. Our national obsession with potassium. Am J Med. 1982;73:155-159.
54. Velázquez H, Wright FS. Control by drugs of renal potassium handling. Ann Rev Pharmacol Toxicol. 1986;26:293-309.
55. Okusa MD, Velazquez H, Ellison DH, Wright FS. Luminal calcium regulates potassium transport by the renal distal tubule. Am J Physiol. 1990;258:F423-F428.
56. Sansom SC, Welling PA. Two channels for one job. Kidney Int. 2007;72:529-530.
57. Myers MG. Diuretic therapy and ventricular arrhythmias in persons 65 years of age and older. Am J Cardiol. 1990;65:599-603.
58. Siegel D, Hulley SB, Black DM, Cheitlin MD, Sebastian A, Seeley DG, Hearst N, Fine R. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA. 1992;267: 1083-1089.
59. Siscovick DS, Raghunathan TE, Psaty BM, Koepsell TD, Wicklund KG, Lin X, Cobb L, Rautaharju PM, Copass MK, Wagner EH. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med. 1994;330:1852-1857.
60. Ellison DH. Salt-Wasting Disorders. In: DuBose TD J, Hamm LL, eds. Acid-Base and Electrolyte Disorders. Philadelphia, PA: Saunders; 2002: 311-334.
61. Foglia PE, Bettinelli A, Tosetto C, Cortesi C, Crosazzo L, Edefonti A, Bianchetti MG. Cardiac work up in primary renal hypokalaemiahypomagnesaemia (Gitelman syndrome). Nephrol Dial Transplant. 2004;19:1398-1402.
62. Scognamiglio R, Negut C, Calo LA. Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes. Clin Nephrol. 2007;67: 193-197.
63. Carter BL, Einhorn PT, Brands M, He J, Cutler JA, Whelton PK, Bakris GL, Brancati FL, Cushman WC, Oparil S, Wright JT Jr. Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute. Hypertension. 2008;52:30-36.
64. Seino S, Iwanaga T, Nagashima K, Miki T. Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice. Diabetes. 2000;49:311-318.
65. Sandström P.-E. Inhibition by hydrochlorothiazide of insulin release and calcium influx in mouse pancreatic b-cells. Br J Pharmacol. 1993;110: 1359-1362.
66. Gillis KD, Gee WM, Hammoud A, McDaniel ML, Falke LC, Misler S. Effects of sulfonamides on a metabolite-regulated ATPi-sensitive K+ channel in rat pancreatic B-cells. Am J Physiol. 1989;257:C1119-C1127.
67. Kudoh T, Nagawaga T, Nakagawa I. Additional small amounts of diuretics improve blood pressure control at low cost without disadvantages in blood sugar metabolism. Hypertens Res. 2008;31:455-462.
68. Townsend RR, Holland OB. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension. Arch Intern Med. 1990;150:1175-1183.
69. Cruz DN, Shaer AJ, Bia MJ, Lifton RP, Simon DB. Gitelman's syndrome revisited: an evaluation of symptoms and healthrelated quality of life. Kidney Int. 2001;59:710-717.
70. Siegel D, Meier J, Maas C, Lopez J, Swislocki AL. The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients. Am J Hypertens. 2008;21:438-442.
71. Maitland-van der Zee AH, Turner ST, Schwartz GL, Chapman AB, Klungel OH, Boerwinkle E. Demographic, environmental, and genetic predictors of metabolic side effects of hydrochlorothiazide treatment in hypertensive subjects. Am J Hypertens. 2005;18:1077-1083.
72. Loffing J, Loffing-Cueni D, Hegyi I, Kaplan MR, Hebert SC, Le Hir M, Kaissling B. Thiazide treatment of rats provokes apoptosis in distal tubule cells. Kidney Int. 1996;50:1180-1190.
73. Costanzo LS. Localization of diuretic action in microperfused rat distal tubules: Ca and Na transport. Am J Physiol. 1985;248:F527-F535.
74. Bartter FC, Pronove P, Gill JR, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. Am J Med. 1962;33:811-828.
75. Pierratos A, Couture RA, Hierlihy PJ, Bell RC, Levine DZ. Bartter's syndrome, nephrocalcinosis and renal insufficiency. CMAJ. 1989;141: 1055-1057.
76. Bonfante L, Davis PA, Spinello M, Antonello A, D'Angelo A, Semplicini A, Calo L. Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman's syndrome. Am J Kidney Dis. 2001;38:165-168.
77. Joo KW, Lee JW, Jang HR, Heo NJ, Jeon US, Oh YK, Lim CS, Na KY, Kim J, Cheong HI, Han JS. Reduced urinary excretion of thiazidesensitive Na-Cl cotransporter in Gitelman syndrome: preliminary data. Am J Kidney Dis. 2007;50:765-773.
78. Loffing J, Vallon V, Loffing-Cueni D, Aregger F, Richter K, Pietri L, Bloch-Faure M, Hoenderop JG, Shull GE, Meneton P, Kaissling B. Altered renal distal tubule structure and renal Na(+) and Ca(2+) handling in a mouse model for Gitelman's syndrome. J Am Soc Nephrol. 2004;15:2276-2288.
79. Schmitt R, Ellison DH, Farman N, Rossier B, Reilly RF, Kunchaparty S, Reeves WB, Oberbäumer I, Tapp R, Bachmann S. Developmental expression of sodium entry pathways in rat distal nephron. Am J Physiol. 1999;276:F367-F381.
80. Loffing J, Loffing-Cueni D, Macher A, Hebert SC, Olson B, Knepper MA, Rossier BC, Kaissling B. Localization of epithelial sodium channel and aquaporin-2 in rabbit kidney cortex. Am J Physiol Renal Physiol. 2000;278:F530-F539.
81. Loffing J, Loffing-Cueni D, Valderrabano V, Klausli L, Hebert SC, Rossier BC, Hoenderop JG, Bindels RJ, Kaissling B. Distribution of transcellular calcium and sodium transport pathways along mouse distal nephron. Am J Physiol Renal Physiol. 2001;281:F1021-F1027.
82. Loffing J, Le Hir M, Kaissling B. Modulation of salt transport rate affects DNA synthesis in vivo in rat renal tubules. Kidney Int. 1995;47: 1615-1623.
83. Okusa MD, Erik A, Persson G, Wright FS. Chlorothiazide effect on feedback-mediated control of glomerular filtration rate. Am J Physiol. 1989;257:F137-F144.
84. Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005;165:936-946.
85. Uzu T, Harada T, Namba T, Yamamoto R, Takahara K, Yamauchi A, Kimura G. Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators. J Hypertens. 2005;23:861-865.
86. Bakris GL, Toto RD, McCullough PA, Rocha R, Purkayastha D, Davis P. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. Kidney Int. 2008;73:1303-1309.
87. Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, Simon DB, Newton-Cheh C, State MW, Levy D, Lifton RP. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet. 2008;40:592-599.
88. Chapman AB, Schwartz GL, Boerwinkle E, Turner ST. Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. Kidney Int. 2002;61:1047-1055.